Abstract
This chapter provides an overview of the major epigenetic mechanisms, such as DNA methylation, histone modifications, and miRNA, and describes those epigenetic mechanisms that are altered in non-CDH1 associated familial gastric cancer. Moreover, we also discuss the clinical implications of the epigenome characterization for this familial gastric cancer setting, regarding its potential in therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CIN:
-
Chromosomal Instability
- DNMT:
-
DNA Methyltransferase
- HAT:
-
Histone Acethyltransferase
- HDAC:
-
Histone Deacethylase
- HDGC:
-
Hereditary Diffuse Gastric Cancer
- HNPCC:
-
Hereditary Non-Polyposis Colorectal Cancer
- miRNA:
-
microRNA
- MSI:
-
Microsatellite Instability
- MMR:
-
Mismatch Repair
- PTM:
-
Post-Translational Modification
- UTR:
-
Untranslated Region
References
Altuvia Y, Landgraf P, Lithwick G, Elefant N, Pfeffer S, Aravin A, Brownstein MJ, Tuschl T, Margalit H (2005) Clustering and conservation patterns of human microRNAs. Nucleic Acids Res 33(8):2697–2706. doi:10.1093/nar/gki567
Amedei A, Benagiano M, della Bella C, Niccolai E, D’Elios MM (2011) Novel immunotherapeutic strategies of gastric cancer treatment. J Biomed Biotechnol 2011:437348. doi:10.1155/2011/437348
Bae SI, Lee HS, Kim SH, Kim WH (2002) Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers. Br J Cancer 86(12):1888–1892. doi:10.1038/sj.bjc.6600372
Banno K, Kisu I, Yanokura M, Tsuji K, Masuda K, Ueki A, Kobayashi Y, Yamagami W, Nomura H, Tominaga E, Susumu N, Aoki D (2012) Epimutation and cancer: a new carcinogenic mechanism of Lynch syndrome (Review). Int J Oncol 41(3):793–797. doi:10.3892/ijo.2012.1528
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297. doi:S0092867404000455
Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A (2009) An operational definition of epigenetics. Genes Dev 23(7):781–783. doi:10.1101/gad.1787609
Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16(1):6–21. doi:10.1101/gad.947102
Bird A (2007) Perceptions of epigenetics. Nature 447(7143):396–398. doi:10.1038/nature05913
Burgess DJ (2012) Epigenetics: asymmetric complexity of the histone code. Nat Rev Genet 13(11):756. doi:10.1038/nrg3360
Caldas C, Carneiro F, Lynch HT, Yokota J, Wiesner GL, Powell SM, Lewis FR, Huntsman DG, Pharoah PD, Jankowski JA, MacLeod P, Vogelsang H, Keller G, Park KG, Richards FM, Maher ER, Gayther SA, Oliveira C, Grehan N, Wight D, Seruca R, Roviello F, Ponder BA, Jackson CE (1999) Familial gastric cancer: overview and guidelines for management. J Med Genet 36(12):873–880
Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM (2002) Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99(24):15524–15529. doi:10.1073/pnas.242606799
Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101(9):2999–3004. doi:10.1073/pnas.0307323101
Campos EI, Reinberg D (2009) Histones: annotating chromatin. Annu Rev Genet 43:559–599. doi:10.1146/annurev.genet.032608.103928
Carthew RW, Sontheimer EJ (2009) Origins and mechanisms of miRNAs and siRNAs. Cell 136(4):642–655. doi:10.1016/j.cell.2009.01.035
Carvalho B, Pinto M, Cirnes L, Oliveira C, Machado JC, Suriano G, Hamelin R, Carneiro F, Seruca R (2003) Concurrent hypermethylation of gene promoters is associated with a MSI-H phenotype and diploidy in gastric carcinomas. Eur J Cancer 39(9):1222–1227. doi:S0959804903001771
Chang TC, Mendell JT (2007) microRNAs in vertebrate physiology and human disease. Annu Rev Genomics Hum Genet 8:215–239. doi:10.1146/annurev.genom.8.080706.092351
Chong JM, Fukayama M, Hayashi Y, Takizawa T, Koike M, Konishi M, Kikuchi-Yanoshita R, Miyaki M (1994) Microsatellite instability in the progression of gastric carcinoma. Cancer Res 54(17):4595–4597
Cocucci E, Racchetti G, Meldolesi J (2009) Shedding microvesicles: artefacts no more. Trends Cell Biol 19(2):43–51. doi:10.1016/j.tcb.2008.11.003
Cowan LA, Talwar S, Yang AS (2010) Will DNA methylation inhibitors work in solid tumors? a review of the clinical experience with azacitidine and decitabine in solid tumors. Epigenomics 2(1):71–86. doi:10.2217/epi.09.44
Cross SH, Bird AP (1995) CpG islands and genes. Curr Opin Genet Dev 5(3):309–314. doi:0959-437X(95)80044-1
Davalos V, Esteller M (2010) MicroRNAs and cancer epigenetics: a macrorevolution. Curr Opin Oncol 22(1):35–45. doi:10.1097/CCO.0b013e328333dcbb
Daxinger L, Whitelaw E (2012) Understanding transgenerational epigenetic inheritance via the gametes in mammals. Nat Rev Genet 13(3):153–162. doi:10.1038/nrg3188
Dong W, Tu S, Xie J, Sun P, Wu Y, Wang L (2009) Frequent promoter hypermethylation and transcriptional downregulation of BTG4 gene in gastric cancer. Biochem Biophys Res Commun 387(1):132–138. doi:10.1016/j.bbrc.2009.06.140
Ehrlich M (2002) DNA methylation in cancer: too much, but also too little. Oncogene 21(35):5400–5413. doi:10.1038/sj.onc.1205651
Esteller M (2008) Epigenetics in cancer. N Engl J Med 358(11):1148–1159. doi:10.1056/NEJMra072067
Esteller M, Corn PG, Baylin SB, Herman JG (2001) A gene hypermethylation profile of human cancer. Cancer Res 61(8):3225–3229
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917. doi:10.1002/ijc.25516
Fitzgerald RC, Hardwick R, Huntsman D, Carneiro F, Guilford P, Blair V, Chung DC, Norton J, Ragunath K, Van Krieken JH, Dwerryhouse S, Caldas C (2010) Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet 47(7):436–444. doi:10.1136/jmg.2009.074237
Fleisher AS, Esteller M, Wang S, Tamura G, Suzuki H, Yin J, Zou TT, Abraham JM, Kong D, Smolinski KN, Shi YQ, Rhyu MG, Powell SM, James SP, Wilson KT, Herman JG, Meltzer SJ (1999) Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res 59(5):1090–1095
Galasso M, Sandhu SK, Volinia S (2012) MicroRNA expression signatures in solid malignancies. Cancer J 18(3):238–243. doi:10.1097/PPO.0b013e318258b5f4
Ganesan A, Nolan L, Crabb SJ, Packham G (2009) Epigenetic therapy: histone acetylation, DNA methylation and anti-cancer drug discovery. Curr Cancer Drug Targets 9(8):963–981
Garzon R, Calin GA, Croce CM (2009) MicroRNAs in cancer. Annu Rev Med 60:167–179. doi:10.1146/annurev.med.59.053006.104707
Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, Leonhardt H, Jaenisch R (2003) Induction of tumors in mice by genomic hypomethylation. Science 300(5618):489–492. doi:10.1126/science.1083558
Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE (1998) E-cadherin germline mutations in familial gastric cancer. Nature 392(6674):402–405. doi:10.1038/32918
Gylling A, Ridanpaa M, Vierimaa O, Aittomaki K, Avela K, Kaariainen H, Laivuori H, Poyhonen M, Sallinen SL, Wallgren-Pettersson C, Jarvinen HJ, Mecklin JP, Peltomaki P (2009) Large genomic rearrangements and germline epimutations in Lynch syndrome. Int J Cancer 124(10):2333–2340. doi:10.1002/ijc.24230
He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5(7):522–531. doi:10.1038/nrg1379
He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ, Hammond SM (2005) A microRNA polycistron as a potential human oncogene. Nature 435(7043):828–833. doi:10.1038/nature03552
Herman JG, Baylin SB (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349(21):2042–2054. doi:10.1056/NEJMra023075
Holm TM, Jackson-Grusby L, Brambrink T, Yamada Y, Rideout WM 3rd, Jaenisch R (2005) Global loss of imprinting leads to widespread tumorigenesis in adult mice. Cancer Cell 8(4):275–285. doi:10.1016/j.ccr.2005.09.007
Hudler P, Vouk K, Liovic M, Repse S, Juvan R, Komel R (2004) Mutations in the hMLH1 gene in Slovenian patients with gastric carcinoma. Clin Genet 65(5):405–411. doi:10.1111/j.0009-9163.2004.0234
Hummel R, Hussey DJ, Haier J (2010) MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. Eur J Cancer 46(2):298–311. doi:10.1016/j.ejca.2009.10.027
Iero M, Valenti R, Huber V, Filipazzi P, Parmiani G, Fais S, Rivoltini L (2008) Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ 15(1):80–88. doi:10.1038/sj.cdd.4402237
Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33(Suppl):245–254. doi:10.1038/ng1089
Jenuwein T, Allis CD (2001) Translating the histone code. Science 293(5532):1074–1080. doi:10.1126/science.1063127
Jones PA (2002) DNA methylation and cancer. Oncogene 21(35):5358–5360. doi:10.1038/sj.onc.1205597
Jones PA (2012) Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 13(7):484–492. doi:10.1038/nrg3230
Jones PA, Baylin SB (2007) The epigenomics of cancer. Cell 128(4):683–692. doi:10.1016/j.cell.2007.01.029
Jones PA, Liang G (2009) Rethinking how DNA methylation patterns are maintained. Nat Rev Genet 10(11):805–811. doi:10.1038/nrg2651
Kanemitsu K, Kawasaki K, Nakamura M, Li D, Yasuda T, Kuroda D, Yokozaki H, Kamigaki T, Kuroda Y (2007) MSI is frequently recognized among gastric cancer patients with a family history of cancer. Hepatogastroenterology 54(80):2410–2414
Keller G, Grimm V, Vogelsang H, Bischoff P, Mueller J, Siewert JR, Hofler H (1996) Analysis for microsatellite instability and mutations of the DNA mismatch repair gene hMLH1 in familial gastric cancer. Int J Cancer 68(5):571–576. doi:10.1002/(SICI)1097-0215(19961127)68:5<571::AID-IJC3>3.0.CO;2-W
Keller G, Rudelius M, Vogelsang H, Grimm V, Wilhelm MG, Mueller J, Siewert JR, Hofler H (1998) Microsatellite instability and loss of heterozygosity in gastric carcinoma in comparison to family history. Am J Pathol 152(5):1281–1289
Khushalani NI (2012) Phase I and II clinical trials for gastric cancer. Surg Oncol Clin N Am 21(1):113–128. doi:10.1016/j.soc.2011.09.006
Kim JK, Samaranayake M, Pradhan S (2009) Epigenetic mechanisms in mammals. Cell Mol Life Sci 66(4):596–612. doi:10.1007/s00018-008-8432-4
Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68(4):820–823
Kouzarides T (2007) Chromatin modifications and their function. Cell 128(4):693–705. doi:10.1016/j.cell.2007.02.005
Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–49
Lee Y, Jeon K, Lee JT, Kim S, Kim VN (2002) MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 21(17):4663–4670
Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, Kim VN (2004) MicroRNA genes are transcribed by RNA polymerase II. EMBO J 23(20):4051–4060. doi:10.1038/sj.emboj.7600385
Leite M, Corso G, Sousa S, Milanezi F, Afonso LP, Henrique R, Soares JM, Castedo S, Carneiro F, Roviello F, Oliveira C, Seruca R (2011) MSI phenotype and MMR alterations in familial and sporadic gastric cancer. Int J Cancer 128(7):1606–1613. doi:10.1002/ijc.25495
Lengauer C, Kinzler KW, Vogelstein B (1997) Genetic instability in colorectal cancers. Nature 386(6625):623–627. doi:10.1038/386623a0
Leung SY, Yuen ST, Chung LP, Chu KM, Chan AS, Ho JC (1999) hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res 59(1):159–164
Liu B, Parsons R, Papadopoulos N, Nicolaides NC, Lynch HT, Watson P, Jass JR, Dunlop M, Wyllie A, Peltomaki P, de la Chapelle A, Hamilton SR, Vogelstein B, Kinzler KW (1996) Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 2(2):169–174
Liu L, Wu N, Li J (2012) Novel targeted agents for gastric cancer. J Hematol Oncol 5:31. doi:10.1186/1756-8722-5-31
Lopez-Serra P, Esteller M (2012) DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene 31(13):1609–1622. doi:10.1038/onc.2011.354
Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR (2005) MicroRNA expression profiles classify human cancers. Nature 435(7043):834–838. doi:10.1038/nature03702
Macdonald JS (2005) Role of post-operative chemoradiation in resected gastric cancer. J Surg Oncol 90(3):166–170. doi:10.1002/jso.20223
Machado JC, Oliveira C, Carvalho R, Soares P, Berx G, Caldas C, Seruca R, Carneiro F, Sobrinho-Simoes M (2001) E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 20(12):1525–1528. doi:10.1038/sj.onc.1204234
Melo SA, Esteller M (2011) Dysregulation of microRNAs in cancer: playing with fire. FEBS Lett 585(13):2087–2099. doi:10.1016/j.febslet.2010.08.009
Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, Jiang J, Schmittgen TD, Patel T (2006) Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130(7):2113–2129. doi:10.1053/j.gastro.2006.02.057
Niessen RC, Hofstra RM, Westers H, Ligtenberg MJ, Kooi K, Jager PO, de Groote ML, Dijkhuizen T, Olderode-Berends MJ, Hollema H, Kleibeuker JH, Sijmons RH (2009) Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome. Genes Chromosomes Cancer 48(8):737–744. doi:10.1002/gcc.20678
Oh HK, Tan AL, Das K, Ooi CH, Deng NT, Tan IB, Beillard E, Lee J, Ramnarayanan K, Rha SY, Palanisamy N, Voorhoeve PM, Tan P (2011) Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer. Clin Cancer Res 17(9):2657–2667. doi:1078-0432.CCR-10-3152
Ohshima K, Inoue K, Fujiwara A, Hatakeyama K, Kanto K, Watanabe Y, Muramatsu K, Fukuda Y, Ogura S, Yamaguchi K, Mochizuki T (2010) Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One 5(10):e13247. doi:10.1371/journal.pone.0013247
Oliveira C, Senz J, Kaurah P, Pinheiro H, Sanges R, Haegert A, Corso G, Schouten J, Fitzgerald R, Vogelsang H, Keller G, Dwerryhouse S, Grimmer D, Chin SF, Yang HK, Jackson CE, Seruca R, Roviello F, Stupka E, Caldas C, Huntsman D (2009a) Germline CDH1 deletions in hereditary diffuse gastric cancer families. Hum Mol Genet 18(9):1545–1555. doi:10.1093/hmg/ddp046
Oliveira C, Seruca R, Carneiro F (2009b) Hereditary gastric cancer. Best Pract Res Clin Gastroenterol 23(2):147–157. doi:10.1016/j.bpg.2009.02.003
Oliveira C, Sousa S, Pinheiro H, Karam R, Bordeira-Carrico R, Senz J, Kaurah P, Carvalho J, Pereira R, Gusmao L, Wen X, Cipriano MA, Yokota J, Carneiro F, Huntsman D, Seruca R (2009c) Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterology 136(7):2137–2148. doi:10.1053/j.gastro.2009.02.065
Ottini L, Palli D, Falchetti M, D’Amico C, Amorosi A, Saieva C, Calzolari A, Cimoli F, Tatarelli C, De Marchis L, Masala G, Mariani-Costantini R, Cama A (1997) Microsatellite instability in gastric cancer is associated with tumor location and family history in a high-risk population from Tuscany. Cancer Res 57(20):4523–4529
Ottini L, Falchetti M, Lupi R, Rizzolo P, Agnese V, Colucci G, Bazan V, Russo A (2006) Patterns of genomic instability in gastric cancer: clinical implications and perspectives. Ann Oncol 17(Suppl 7):vii97–vii102. doi:10.1093/annonc/mdl960
Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y, Pignon JP, Rougier P, Sakamoto J, Sargent D, Sasako M, Van Cutsem E, Buyse M (2010) Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA 303(17):1729–1737. doi:10.1001/jama.2010.534
Park JH, Park J, Choi JK, Lyu J, Bae MG, Lee YG, Bae JB, Park DY, Yang HK, Kim TY, Kim YJ (2011) Identification of DNA methylation changes associated with human gastric cancer. BMC Med Genomics 4:82. doi:10.1186/1755-8794-4-82
Pedrazzani C, Corso G, Velho S, Leite M, Pascale V, Bettarini F, Marrelli D, Seruca R, Roviello F (2009) Evidence of tumor microsatellite instability in gastric cancer with familial aggregation. Fam Cancer 8(3):215–220. doi:10.1007/s10689-008-9231-7
Peltomaki P (2012) Mutations and epimutations in the origin of cancer. Exp Cell Res 318(4):299–310. doi:10.1016/j.yexcr.2011.12.001
Pinto M, Oliveira C, Cirnes L, Carlos Machado J, Ramires M, Nogueira A, Carneiro F, Seruca R (2003) Promoter methylation of TGFbeta receptor I and mutation of TGFbeta receptor II are frequent events in MSI sporadic gastric carcinomas. J Pathol 200(1):32–38. doi:10.1002/path.1327
Pinto M, Wu Y, Mensink RG, Cirnes L, Seruca R, Hofstra RM (2008) Somatic mutations in mismatch repair genes in sporadic gastric carcinomas are not a cause but a consequence of the mutator phenotype. Cancer Genet Cytogenet 180(2):110–114. doi:10.1016/j.cancergencyto.2007.09.022
Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ (2006) Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20(9):1487–1495. doi:10.1038/sj.leu.2404296
Richards EJ (2006) Inherited epigenetic variation–revisiting soft inheritance. Nat Rev Genet 7(5):395–401. doi:10.1038/nrg1834
Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A (2004) Identification of mammalian microRNA host genes and transcription units. Genome Res 14(10A):1902–1910. doi:10.1101/gr.2722704
Rodriguez-Paredes M, Esteller M (2011) Cancer epigenetics reaches mainstream oncology. Nat Med 17(3):330–339. doi:10.1038/nm.2305
Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA, Jones PA (2006) Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9(6):435–443. doi:10.1016/j.ccr.2006.04.020
Sandoval J, Esteller M (2012) Cancer epigenomics: beyond genomics. Curr Opin Genet Dev 22(1):50–55. doi:10.1016/j.gde.2012.02.008
Scarano MI, Strazzullo M, Matarazzo MR, D’Esposito M (2005) DNA methylation 40 years later: its role in human health and disease. J Cell Physiol 204(1):21–35. doi:10.1002/jcp.20280
Sharma S, Kelly TK, Jones PA (2010) Epigenetics in cancer. Carcinogenesis 31(1):27–36. doi:10.1093/carcin/bgp220
Shen L, Kondo Y, Guo Y, Zhang J, Zhang L, Ahmed S, Shu J, Chen X, Waterland RA, Issa JP (2007) Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. PLoS Genet 3(10):2023–2036. doi:10.1371/journal.pgen.0030181
Shigaki H, Baba Y, Watanabe M, Murata A, Iwagami S, Miyake K, Ishimoto T, Iwatsuki M, Baba H (2012) LINE-1 hypomethylation in gastric cancer, detected by bisulfite pyrosequencing, is associated with poor prognosis. Gastric Cancer. doi:10.1007/s10120-012-0209-7
Shinmura K, Yin W, Isogaki J, Saitoh K, Kanazawa K, Koda K, Yokota J, Kino I, Arai T, Sugimura H (1997) Stage-dependent evaluation of microsatellite instability in gastric carcinoma with familial clustering. Cancer Epidemiol Biomarkers Prev 6(9):693–697
Skinner MK (2011) Environmental epigenetic transgenerational inheritance and somatic epigenetic mitotic stability. Epigenetics 6(7):838–842. doi:10.4161/epi.6.7.16537
Skinner MK, Manikkam M, Guerrero-Bosagna C (2010) Epigenetic transgenerational actions of environmental factors in disease etiology. Trends Endocrinol Metab 21(4):214–222. doi:10.1016/j.tem.2009.12.007
Strahl BD, Allis CD (2000) The language of covalent histone modifications. Nature 403(6765):41–45. doi:10.1038/47412
Suzuki K, Suzuki I, Leodolter A, Alonso S, Horiuchi S, Yamashita K, Perucho M (2006) Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell 9(3):199–207. doi:10.1016/j.ccr.2006.02.016
Taby R, Issa JP (2010) Cancer epigenetics. CA Cancer J Clin 60(6):376–392. doi:10.3322/caac.20085
Takashima A, Yamada Y, Nakajima TE, Kato K, Hamaguchi T, Shimada Y (2009) Standard first-line chemotherapy for metastatic gastric cancer in Japan has met the global standard: evidence from recent phase III trials. Gastrointest Cancer Res 3(6):239–244
Tan J, Cang S, Ma Y, Petrillo RL, Liu D (2010) Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. J Hematol Oncol 3:5. doi:10.1186/1756-8722-3-5
Turner BM (2000) Histone acetylation and an epigenetic code. Bioessays 22(9):836–845. doi:10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X
Ushijima T, Nakajima T, Maekita T (2006) DNA methylation as a marker for the past and future. J Gastroenterol 41(5):401–407. doi:10.1007/s00535-006-1846-6
Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6):654–659. doi:10.1038/ncb1596
Valeri N, Gasparini P, Fabbri M, Braconi C, Veronese A, Lovat F, Adair B, Vannini I, Fanini F, Bottoni A, Costinean S, Sandhu SK, Nuovo GJ, Alder H, Gafa R, Calore F, Ferracin M, Lanza G, Volinia S, Negrini M, McIlhatton MA, Amadori D, Fishel R, Croce CM (2010) Modulation of mismatch repair and genomic stability by miR-155. Proc Natl Acad Sci U S A 107(15):6982–6987. doi:10.1073/pnas.1002472107
Valladares-Ayerbes M, Reboredo M, Medina-Villaamil V, Iglesias-Diaz P, Lorenzo-Patino MJ, Haz M, Santamarina I, Blanco M, Fernandez-Tajes J, Quindos M, Carral A, Figueroa A, Anton-Aparicio LM, Calvo L (2012) Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer. J Transl Med 10:186. doi:10.1186/1479-5876-10-186
Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103(7):2257–2261. doi:10.1073/pnas.0510565103
Wang GG, Allis CD, Chi P (2007) Chromatin remodeling and cancer, part I: covalent histone modifications. Trends Mol Med 13(9):363–372. doi:10.1016/j.molmed.2007.07.003
Wu PY, Zhang Z, Wang JM, Guo WW, Xiao N, He Q, Wang YP, Fan YM (2012) Germline promoter hypermethylation of tumor suppressor genes in gastric cancer. World J Gastroenterol 18(1):70–78. doi:10.3748/wjg.v18.i1.70
Yanagisawa Y, Akiyama Y, Iida S, Ito E, Nomizu T, Sugihara K, Yuasa Y, Maruyama K (2000) Methylation of the hMLH1 promoter in familial gastric cancer with microsatellite instability. Int J Cancer 85(1):50–53. doi:10.1002/(SICI)1097-0215(20000101)85:1<50::AID-IJC9>3.0.CO;2-E
You JS, Jones PA (2012) Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell 22(1):9–20. doi:10.1016/j.ccr.2012.06.008
Acknowledgements 
This study was supported by the Portuguese Foundation for Science and Technology (Post-Doc grant to Marina Leite, reference SFRH/BPD/33420/2008). IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by FCT, the Portuguese Foundation for Science and Technology.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Leite, M. et al. (2013). Non-CDH1-Associated Familial Gastric Cancer and Epigenetics Factors. In: Corso, G., Roviello, F. (eds) Spotlight on Familial and Hereditary Gastric Cancer. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6570-2_10
Download citation
DOI: https://doi.org/10.1007/978-94-007-6570-2_10
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6569-6
Online ISBN: 978-94-007-6570-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)